Related references
Note: Only part of the references are listed.Long-Term Monitoring Shows Hepatitis B Virus Resistance to Entecavir in Nucleoside-Naive Patients Is Rare Through 5 Years of Therapy
Daniel J. Tenney et al.
HEPATOLOGY (2009)
Enhanced intracellular retention of a hepatitis B virus strain associated with fulminant hepatitis
Jun Inoue et al.
VIROLOGY (2009)
Low risk of adefovir resistance in lamivudine-resistant chronic hepatitis B patients treated with adefovir plus lamivudine combination therapy: Two-year follow-up
Hiromi Yatsuji et al.
JOURNAL OF HEPATOLOGY (2008)
Tenofovir monotherapy is effective in hepatitis B patients with antiviral treatment failure to adefovir in the absence of adefovir-resistant mutations
Jessica Tan et al.
JOURNAL OF HEPATOLOGY (2008)
Lamivudine-resistant chronic hepatitis B: An observational study on adefovir in monotherapy or in combination with lamivudine
Silvia Gala et al.
JOURNAL OF HEPATOLOGY (2008)
Evaluation of initial virological response to adefovir and development of adefovir-resistant mutations in patients with chronic hepatitis B
A. Gallego et al.
JOURNAL OF VIRAL HEPATITIS (2008)
Therapeutic strategies in the management of patients with chronic hepatitis B virus infection
George V. Popotheodoridis et al.
LANCET INFECTIOUS DISEASES (2008)
Tenofovir plus lamivudine as rescue therapy for adefovir-resistant chronic hepatitis B in hepatitis B e antigen-positive patients with liver cirrhosis
Won Hyeok Choe et al.
LIVER INTERNATIONAL (2008)
Drug therapy - Hepatitis B virus infection
Jules L. Dienstag
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Low resistance to adefovir combined with lamivudine: A 3-year study of 145 lamivudine-resistant hepatitis B patients
Pie-Fro Lampertico et al.
GASTROENTEROLOGY (2007)
Early virological suppression is associated with good maintained response to adefovir dipivoxil in lamivudine resistant chronic hepatitis B
H. L. -Y. Chan et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Two-year assessment of entecavir resistance in lamivudine-refractory hepatitis B virus patients reveals different clinical outcomes depending on the resistance substitutions present
Daniel J. Tenney et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Adding-on versus switching-to adefovir therapy in lamivudine-resistant HBeAg-negative chronic hepatitis B
Irene Rapti et al.
HEPATOLOGY (2007)
Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years
Stephanos J. Hadziyannis et al.
GASTROENTEROLOGY (2006)
Selection of a multiple drug-resistant hepatitis B virus strain in a liver-transplanted patient
Stephanie Villet et al.
GASTROENTEROLOGY (2006)
Response to long-term lamivudine treatment in patients infected with hepatitis B virus genotypes A, B, and C
Mariko Kobayashi et al.
JOURNAL OF MEDICAL VIROLOGY (2006)
Tenofovir for patients with lamivudine-resistant hepatitis B virus (HBV) infection and high HBV DNA level during adefovir therapy
Florian van Boemmel et al.
HEPATOLOGY (2006)
A case-control study of response to lamivudine therapy for 2 years in Japanese and Chinese patients chronically infected with hepatitis B virus of genotypes Bj, Ba and C
Etsuro Orito et al.
HEPATOLOGY RESEARCH (2006)
HBV drug resistance: Mechanisms, detection and interpretation
T Shaw et al.
JOURNAL OF HEPATOLOGY (2006)
Virologic response and resistance to adefovir in patients with chronic hepatitis B
SK Fung et al.
JOURNAL OF HEPATOLOGY (2006)
Adefovir-resistant hepatitis B can be associated with viral rebound and hepatic decompensation
SK Fung et al.
JOURNAL OF HEPATOLOGY (2005)
A dose-ranging study of the efficacy and tolerability of entecavir in lamivudine-refractory chronic hepatitis B patients
TT Chang et al.
GASTROENTEROLOGY (2005)
Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B
SJ Hadziyannis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Susceptibility to antivirals of a human HBV strain with mutations conferring resistance to both lamivudine and adefovir
MN Brunelle et al.
HEPATOLOGY (2005)
Activity of adefovir dipivoxil against all patterns of lamivudine-resistant hepatitis B viruses in patients
CE Westland et al.
JOURNAL OF VIRAL HEPATITIS (2005)
Mechanisms of disease: Hepatitis B virus infection - Natural history and clinical consequences
D Ganem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to lamivudine
DJ Tenney et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Viral features of lamivudine resistant hepatitis B genotypes A and D
B Zollner et al.
HEPATOLOGY (2004)
Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B
MG Peters et al.
GASTROENTEROLOGY (2004)
The hepatitis B virus polymerase mutation rtV173L is selected during lamivudine therapy and enhances viral replication in vitro
WE Delaney et al.
JOURNAL OF VIROLOGY (2003)
Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase
P Angus et al.
GASTROENTEROLOGY (2003)
Prevalence and clinical correlates of YMDD variants during lamivudine therapy for patients with chronic hepatitis B
CL Lai et al.
CLINICAL INFECTIOUS DISEASES (2003)
Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B
P Marcellin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Hepatitis B virus resistance to antivirals: clinical implications and management
F Zoulim
JOURNAL OF HEPATOLOGY (2003)
Selection of a hepatitis B virus strain resistant to adefovir in a liver transplantation patient
JP Villeneuve et al.
JOURNAL OF HEPATOLOGY (2003)
The polymerase L528M mutation cooperates with nucleotide binding-site mutations, increasing hepatitis B virus replication and drug resistance
SK Ono et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Long-term therapy of chronic hepatitis B with lamivudine
DTY Lu et al.
HEPATOLOGY (2000)
Clinical features of viral resistance in patients with chronic hepatitis B maintained on long-term lamivudine therapy.
MG Ghany et al.
HEPATOLOGY (2000)
Share Paper
